| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/24/1999 | CN1208635A Application of theaflavine for preparing medicine for treating oral submucosa fibrous disease |
| 02/24/1999 | CN1208634A Application of theaflavine for preparing medicine for treating enterogastric diseases |
| 02/24/1999 | CN1208625A Traditional Chinese medicine bolus for treating bone tuberculosis |
| 02/24/1999 | CN1208622A Application of theaflavine for prepn. of medicine for treating helicobacter pylori related disease |
| 02/23/1999 | US5874565 Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus |
| 02/23/1999 | US5874529 Conformationally constrained backbone cyclized peptide analogs |
| 02/23/1999 | US5874459 Reducing nausea during chemotherapy; therapy for glaucoma, organ transplants |
| 02/23/1999 | US5874457 Imidazolylalkyl derivatives of imidazo 1,5-a!indol-3-one |
| 02/23/1999 | US5874445 (+) -α- (2,3-dimethoxyphenyl)-1-(2-(4-fluorephenyl) ethyl)-4-piepridinemethanol |
| 02/23/1999 | US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor |
| 02/23/1999 | US5874245 Human G-protein coupled receptor (HIBCD07) |
| 02/23/1999 | US5874080 Administering a therapeutic polypeptide antiallergens to inhabit elastase release by neutrophils |
| 02/23/1999 | US5874071 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 02/23/1999 | CA2146007C Substituted quinuclidines |
| 02/23/1999 | CA2100269C Use of 1, 3-oxathiolane nucleoside analogues in the treatment of hepatitis b |
| 02/19/1999 | CA2241433A1 Novel compounds |
| 02/19/1999 | CA2240631A1 Pigr-1, a member of immunoglobulin gene superfamily |
| 02/18/1999 | WO1999007737A2 Lsr receptor, cloning and uses |
| 02/18/1999 | WO1999007736A2 Lipoprotein-regulating medicaments |
| 02/18/1999 | WO1999007733A2 Hepatitis c inhibitor peptides |
| 02/18/1999 | WO1999007729A2 Peptides having potassium channel opener activity |
| 02/18/1999 | WO1999007707A1 8-SUBSTITUTED-9H-1,3-DIOXOLO/4,5-h//2,3/BENZODIAZEPINE DERIVATIVES, AS AMPA/KAINATE RECEPTOR INHIBITORS |
| 02/18/1999 | WO1999007703A1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS |
| 02/18/1999 | WO1999007700A1 Bicyclic compounds as ligands for 5-ht1 receptors |
| 02/18/1999 | WO1999007681A1 2-acylaminopropanamines as tachykinin receptor antagonists |
| 02/18/1999 | WO1999007670A1 Anthranilic acid analogs |
| 02/18/1999 | WO1999007409A1 Product comprising at least a double stranded rna combined with at least an antiviral agent |
| 02/18/1999 | WO1999007399A1 Pharmaceutical composition containing a mixed extract of phellodendron amurense ruprecht cortex and patrinia scabiosaefolia fisch. for treatment of hepatitis c |
| 02/18/1999 | WO1999007363A1 Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment |
| 02/18/1999 | WO1999007351A2 Indole derivatives and their use as mcp-1 antagonists |
| 02/18/1999 | WO1998051348A3 Sustained-release delayed gels |
| 02/18/1999 | DE19735410A1 New stable fumarate salt of pyrimidinol derivative dopamine D3 receptor ligand, having improved solubility and suitable for oral administration |
| 02/18/1999 | CA2301669A1 Peptides having potassium channel opener activity |
| 02/18/1999 | CA2300302A1 8-substituted-9h-1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives, as ampa/kainate receptor inhibitors |
| 02/18/1999 | CA2299554A1 Product comprising at least a double stranded rna combined with at least an antiviral agent |
| 02/18/1999 | CA2299286A1 Bicyclic compounds as ligands for 5-ht1 receptors |
| 02/18/1999 | CA2298849A1 Lipoprotein-regulating medicaments |
| 02/18/1999 | CA2298702A1 2-acylaminopropanamines as tachykinin receptor antagonists |
| 02/18/1999 | CA2297409A1 Anthranilic acid analogs |
| 02/18/1999 | CA2297290A1 Chemical compounds |
| 02/18/1999 | CA2294049A1 Hepatitis c inhibitor peptides |
| 02/18/1999 | CA2274302A1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
| 02/18/1999 | CA2245043A1 Ccr-3 receptor antagonists |
| 02/18/1999 | CA2245041A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists |
| 02/17/1999 | EP0897011A2 Novel arginine deiminase |
| 02/17/1999 | EP0897008A2 His5 |
| 02/17/1999 | EP0896822A1 4-Aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists |
| 02/17/1999 | EP0896539A1 Methods for treating emesis and central nervous system disorders using optically pure (+) norcisapride |
| 02/17/1999 | EP0896533A2 Pentafluorobenzenesulfonamides and analogs |
| 02/17/1999 | CN1208420A Antisecretory factor peptides regulating pathological permeability changes |
| 02/17/1999 | CN1208418A Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
| 02/17/1999 | CN1208417A Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 02/17/1999 | CN1208413A Antagonists of gonadotropin releasing hormone |
| 02/17/1999 | CN1208412A Antagonists of gonadotropin releasing hormone |
| 02/17/1999 | CN1208352A Tea, kit and method for treating hemorrhoids |
| 02/17/1999 | CN1208034A Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 02/17/1999 | CN1207945A Balsam pear-natural indig medicine powder |
| 02/17/1999 | CN1207943A Hepatitis curing capsule |
| 02/17/1999 | CN1207929A Baizhong plaster for children |
| 02/17/1999 | CN1207926A Gastrosis plaster |
| 02/17/1999 | CN1207906A Compounding process of oral liquid for liver and bile stone |
| 02/17/1999 | CN1207905A Weichangning powder for curing gastroenteritic diseases |
| 02/17/1999 | CN1207898A Simethicone/anhydrous calcium phosphate compositions |
| 02/16/1999 | US5872146 Metalloproteinases involved in connective tissue breakdown, such as collagenase, stromelysin and gelatinase and tumor necrosis factor |
| 02/16/1999 | US5872131 Phenyl-oxo-alkyl-(4-piperidinyl)benzoate derivatives |
| 02/16/1999 | US5872125 Polymorphs of lesopitron dihydrochloride and its hydrated forms, preparation processes and compositions containing it |
| 02/16/1999 | US5872001 Lanthionine antibiotic compositions and methods |
| 02/16/1999 | US5871729 Superoxide dismutase-4 |
| 02/16/1999 | US5871714 Compositions for controlling bacterial colonization |
| 02/15/1999 | CA2224096A1 The g-protein coupled receptor hfia041 |
| 02/13/1999 | CA2240627A1 Novel ratc |
| 02/13/1999 | CA2240623A1 Novel rata |
| 02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
| 02/11/1999 | WO1999006547A2 Products of gene and protein therapy of cystic fibrosis and inducers of a glutathiones-s-transferase |
| 02/11/1999 | WO1999006434A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006433A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006423A1 83 human secreted proteins |
| 02/11/1999 | WO1999006404A1 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them |
| 02/11/1999 | WO1999006397A2 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 02/11/1999 | WO1999006391A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 02/11/1999 | WO1999006390A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006367A1 Caspases and apoptosis |
| 02/11/1999 | WO1999006361A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 02/11/1999 | WO1999006354A1 Il-8 receptor antagonists |
| 02/11/1999 | WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 02/11/1999 | WO1999006042A1 Caspases and apoptosis |
| 02/11/1999 | WO1999006041A1 SUBSTITUTED ALKANOHYDROXAMIC ACIDS AND METHOD OF REDUCING TNFα LEVELS |
| 02/11/1999 | WO1999006032A2 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production |
| 02/11/1999 | WO1999006027A1 Pellet-type formulation intended for treating the intestinal tract |
| 02/11/1999 | CA2298935A1 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them |
| 02/11/1999 | CA2298852A1 83 human secreted proteins |
| 02/11/1999 | CA2298668A1 Caspases and apoptosis |
| 02/11/1999 | CA2298617A1 Acyclic metalloprotease inhibitors |
| 02/11/1999 | CA2298062A1 Genetic and protein therapy products for treating cystic fibrosis and inducing a glutathione-s-transferase function |
| 02/11/1999 | CA2297894A1 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 02/11/1999 | CA2297757A1 Caspases and apoptosis |
| 02/11/1999 | CA2295295A1 Substituted alkanohydroxamic acids and method of reducing tnf.alpha. levels |
| 02/11/1999 | CA2294064A1 Il-8 receptor antagonists |
| 02/11/1999 | CA2290750A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290746A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |